This trial provides essential data for the obesity indication in patients with comorbid diabetes and may also support the type 2 diabetes regulatory submission
Where it works: Adipose tissue (fat cells): Reduces inflammation and may improve fat metabolism Pancreas: Works alongside GLP-1 to enhance insulin secretion Brain: May contribute to appetite regulation (research ongoing) Weight loss contribution: When GIP is added to GLP-1 (as in tirzepatide), weight loss increases from ~15% to ~22%
1 H NMR (400 MHz, DMSO) 8.74 (s, 1H), 8.22 (d, J = 8.3 Hz, 1H), 7.50 7.39 (m, 9H), 7.22 (s, 1H), 7.18 7.09 (m, 6H), 6.91 (t, J = 6.0 Hz, 1H), 4.57 (td, J = 9.0, 4.8 Hz, 1H), 3.50 (d, J = 10.9 Hz, 2H), 3.14 (dd, J = 15.0, 4.9 Hz, 1H), 2.94 (dd, J = 15.0, 9.8 Hz, 1H), 1.34 (s, 9H)
The abdomen typically offers a generous layer of subcutaneous fat
[DOI] [PubMed] [Google Scholar] 65.Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al
To Summarize Vitamin B12 injections side effects are incredibly rare, and when reactions occur, they are more likely due to additives rather than the B12 itself